Abeona Therapeutics Announces Initial European Regulatory Approvals for Phase 1/2 Gene Therapy Clinical Studies for Patients With Sanfilippo Syndromes Type A (MPS IIIA) and Type B (MPS IIIB)
January 11, 2016 09:03 ET
|
Abeona Therapeutics
NEW YORK, NY, and CLEVELAND, OH--(Marketwired - January 11, 2016) -
Approval of Genetically Modified Organism (GMO) and Ethical Committee (CEIC) regulatory filings for both ABO-101...
Abeona Therapeutics to Present at Piper Jaffray 27th Annual Healthcare Conference
December 01, 2015 09:03 ET
|
Abeona Therapeutics
NEW YORK, NY--(Marketwired - December 01, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
Abeona Therapeutics to Present at Jefferies 2015 Global Healthcare Conference
November 18, 2015 09:03 ET
|
Abeona Therapeutics
NEW YORK, NY--(Marketwired - November 18, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
Abeona Therapeutics Reports Financial Results and Highlights for Third Quarter 2015
November 17, 2015 09:03 ET
|
Abeona Therapeutics
NEW YORK, NY and CLEVELAND, OH--(Marketwired - November 17, 2015) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and...
Abeona Therapeutics Announces License for Next Generation AAV Delivery Vector for Fanconi Anemia and Rare Blood Disease Platform
October 06, 2015 09:03 ET
|
Abeona Therapeutics Inc.
NEW YORK, NY--(Marketwired - October 06, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO)License enables lead CRISPR/Cas9 program for ABO-301 (AAV-FANCC) for Fanconi anemia and rare blood disorder...
Abeona Therapeutics to Present at 2015 Stem Cell Meeting on the Mesa
October 01, 2015 16:04 ET
|
Abeona Therapeutics Inc.
NEW YORK, NY--(Marketwired - October 01, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
Abeona Therapeutics to Present at 2015 Rodman & Renshaw Annual Global Investment Conference
September 03, 2015 09:03 ET
|
Abeona Therapeutics
NEW YORK, NY--(Marketwired - September 03, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
Abeona Therapeutics to Present at the 2015 Sidoti Emerging Growth Conference
August 24, 2015 09:03 ET
|
Abeona Therapeutics
NEW YORK, NY--(Marketwired - August 24, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
Abeona Therapeutics Announces Recent Highlights and Second Quarter 2015 Conference Call
August 17, 2015 09:03 ET
|
Abeona Therapeutics Inc.
NEW YORK, NY--(Marketwired - August 17, 2015) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
Abeona Therapeutics Announces Closing of Upsized $15.5 Million Equity Financing With Institutional Investors and Management
August 03, 2015 09:03 ET
|
Abeona Therapeutics Inc
NEW YORK, NY--(Marketwired - August 03, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...